Austrian Life Sciences Programme

Austria on the way: becoming a research, production and business location for life sciences

Austria is an active life sciences location with internationally visible, excellent research and development and a growing corporate landscape. Compared to other innovative sectors, the life sciences sector is by far the most innovative, has the highest research rate and contributes significantly to national value creation.

The Austrian Life Sciences Programme supports innovative research and development projects and thus strengthens long-term competitiveness. They contribute significantly to the implementation of national and European strategies in the field of life sciences. The focus addresses the specifics of the industry and offers tailored funding for the entire development cycle. The programme aims to cushion problem areas in the industry (eg long development times, high development risk, strict regulatory requirements, low production capacities, high investment requirements) by providing research funding. 

Based on these objectives, two main goals were defined:

Goal 1: Leverage digitization potential in the healthcare sector.

The promotion of research and development projects for the digitization of health aspects (diagnostics, telemedicine, medical devices, etc.) will be an important lever.

Goal 2: Strengthen research and production location.

In order to prevent know-how from migrating and to increase the attractiveness of Austria as a location for research and production, other funding opportunities are to be examined in addition to funding offers for early development phases. The attractiveness of Austria as a research location in Europe is to be sustainably increased.

In 2022, the budget for the Austrian Life Sciences Programme totals 31 million Euros.

Until the submission deadline of 29.12.2022 (for lead projects 1.9.2022), the funding instruments "company projects industrial research" and "company projects experimental development" (budget - total: € 15 million) as well as "clinical trials - infectious diseases" (budget: € 12 million) and "lead project" (budget: € 4 million) will be offered in a first call.

The essentials in brief

Program Owner / Sponsor BMAW - Federal Ministry for Labour and Economy FFG - Austrian Research Promotion Agency
Project type
Submission with a proposal process
Target group The Austrian Life Sciences Programme is aimed at all companies as well as actors from university and non-university research, universities of applied sciences, higher technical educational institutions based in Austria. The participation of foreign partners is possible (depending on the funding instrument). The participation of actors along the entire value chain is required. Further information and any restrictions can be found in the respective instrument guides and in the call for proposals guide.
What is being funded Funding is provided for R&D company projects and lead projects in the research categories of industrial research or experimental development, as well as clinical trials.
Welche Kosten werden gefördert? All costs attributable to the project that are incurred directly, actually and in addition (to conventional operating expenses) during the funding period according to the funding agreement (e.g. personnel costs, research infrastructure, material and equipment costs, travel costs and third-party costs) are eligible for funding. Details are described in the FFG Cost Guide.
Min. / max. running time 18 - 24 months
Availability from 01.04.2022 - 29.12.2022


Dr. Corinna WILKEN
Dr. Corinna WILKEN
Programmleitung, Expertin Life Sciences
T 0043577551317
Dr. Amrei STREHL
Programm-Management, Expertin Life Sciences
T 0043577551325
Förderberatung, Einreichberatung
T 0043577551518

Additional Information